C-reactive protein and lipid profile in patients with polycystic ovary syndrome treated by metformin
Abstract
Objective: To evaluate the effect of metformin on serum hs-CRP levels and lipid profile in patients with PCOS in Mosul City in Iraq. Methodology: This is a case control study conducted at the Fertility and Sterility Clinic in the Medical Center that belongs to Mosul Medical College / Iraq, from the 1st of November 2009 to the 15th May 2010. A group of 43 women with PCOS of reproductive age who used metformin for more than three months (metformin users), with another ageand body mass index (BMI)-matched group of 53 women with PCOS who did not use metformin (metformin non-users), were included in this study. From each patient, a 10 ml fasting venous blood sample was taken. The serum was used to measure the biochemical parameters using commercially available kits, whereas serum low-density lipoprotein cholesterol (LDL-c) was calculated using Friedewald equation. Atherogenic index (AI) was recognized by simple equation and BMI was calculated as weight in kilograms divided by the squared height in meters. Results: This study revealed a significant lower level of hs-CRP (P = 0.04) in metformin users as compared with metformin non-users. There were a significant lower levels of total cholesterol (TC) (P = 0.003), LDL-c (P < 0.001), AI (P < 0.001) and significantly higher levels of high-density lipoprotein cholesterol (HDL-c)(P = 0.026) in metformin users when compared with metformin non-users, but a non significant reduction in triglycerides (TG) level between the two groups of…
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.